Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Gallerani

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Frontiers in Oncology|March 9, 2023
ARID1A in cancer: Friend or foe?Beatrice Fontana, Giulia Gallerani, Irene Salamon, et al.
Annals of Translational Medicine|December 10, 2014
Circulating tumor cells and epithelial, mesenchymal and stemness markers: characterization of cell subpopulationsGuislaine Barriere, Pietro Fici, Giulia Gallerani, et al.
Medicine|June 17, 2020
Impressive long-term response with chemo-endocrine therapy in a premenopausal patient with metastatic breast cancer: A case reportRoberta Maltoni, Michela Palleschi, Giulia Gallerani, et al.
Oncotargets and Therapy|October 17, 2017
DNA ploidy and S-phase fraction analysis in peritoneal carcinomatosis from ovarian cancer: correlation with clinical pathological factors and response to chemotherapySilvia Carloni, Giulia Gallerani, Anna Tesei, et al.
Journal of Clinical Medicine|February 26, 2025
Vaccine-Based Immunotherapy for Oropharyngeal and Nasopharyngeal CancersDaria Maria Filippini, Elisabetta Broseghini, Carlotta Liberale, et al.
Frontiers in Medicine|March 31, 2022
Case Report: Analysis of Plasma Extracellular Vesicles in a Triple Negative Spindle-Cell Metaplastic Breast Cancer PatientIvan Vannini, Milena Urbini, Mattia Melloni, et al.
Oncotarget|December 3, 2016
Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancerPietro Fici, Giulia Gallerani, Anne-Pierre Morel, et al.
Cancers|September 5, 2020
Single-Cell NGS-Based Analysis of Copy Number Alterations Reveals New Insights in Circulating Tumor Cells Persistence in Early-Stage Breast CancerTania Rossi, Giulia Gallerani, Davide Angeli, et al.
Frontiers in Medicine|July 12, 2021
Case Report: Analysis of Circulating Tumor Cells in a Triple Negative Spindle-Cell Metaplastic Breast Cancer PatientTania Rossi, Michela Palleschi, Davide Angeli, et al.
Cancers|August 26, 2022
Dissecting Molecular Heterogeneity of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients through Copy Number Aberration (CNA) and Single Nucleotide Variant (SNV) Single Cell AnalysisTania Rossi, Davide Angeli, Michela Tebaldi, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Frontiers in Oncology|March 9, 2023
ARID1A in cancer: Friend or foe?Beatrice Fontana, Giulia Gallerani, Irene Salamon, et al.
Annals of Translational Medicine|December 10, 2014
Circulating tumor cells and epithelial, mesenchymal and stemness markers: characterization of cell subpopulationsGuislaine Barriere, Pietro Fici, Giulia Gallerani, et al.
Medicine|June 17, 2020
Impressive long-term response with chemo-endocrine therapy in a premenopausal patient with metastatic breast cancer: A case reportRoberta Maltoni, Michela Palleschi, Giulia Gallerani, et al.
Oncotargets and Therapy|October 17, 2017
DNA ploidy and S-phase fraction analysis in peritoneal carcinomatosis from ovarian cancer: correlation with clinical pathological factors and response to chemotherapySilvia Carloni, Giulia Gallerani, Anna Tesei, et al.
Journal of Clinical Medicine|February 26, 2025
Vaccine-Based Immunotherapy for Oropharyngeal and Nasopharyngeal CancersDaria Maria Filippini, Elisabetta Broseghini, Carlotta Liberale, et al.
Frontiers in Medicine|March 31, 2022
Case Report: Analysis of Plasma Extracellular Vesicles in a Triple Negative Spindle-Cell Metaplastic Breast Cancer PatientIvan Vannini, Milena Urbini, Mattia Melloni, et al.
Oncotarget|December 3, 2016
Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancerPietro Fici, Giulia Gallerani, Anne-Pierre Morel, et al.
Cancers|September 5, 2020
Single-Cell NGS-Based Analysis of Copy Number Alterations Reveals New Insights in Circulating Tumor Cells Persistence in Early-Stage Breast CancerTania Rossi, Giulia Gallerani, Davide Angeli, et al.
Frontiers in Medicine|July 12, 2021
Case Report: Analysis of Circulating Tumor Cells in a Triple Negative Spindle-Cell Metaplastic Breast Cancer PatientTania Rossi, Michela Palleschi, Davide Angeli, et al.
Cancers|August 26, 2022
Dissecting Molecular Heterogeneity of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients through Copy Number Aberration (CNA) and Single Nucleotide Variant (SNV) Single Cell AnalysisTania Rossi, Davide Angeli, Michela Tebaldi, et al.
Pageof 3